Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Star Alliance International Corp. ("STAL") Signs Acquisition Agreement with HRaspirin, Ltd.

In This Article:

LAS VEGAS, NV / ACCESSWIRE / July 16, 2024 / Star Alliance International Corp. (OTC PINK:STAL), ("STAR or the Company"). STAR is pleased to confirm that it has signed definitive documents to acquire 51% of HRaspirin which becomes effective on or before August 15, 2024, based on certain milestones to be achieved.

HRaspirin founded in 2018 was established to solve the challenges faced by employers and HR managers in managing benefits. Employers are not in the business of providing benefits. Employees expect benefits and to be able to purchase other options at discounts through their employer. HRaspirin uses its proprietary software solutions to fill the role for human resources for any company that wants to provide voluntary benefits to its employees but doesn't want to worry about the cost of managing carriers. Businesses have severely cut back budgets for human resources and are having difficulty staffing for these tasks. HRaspirin provides the solution, and the employees enjoy the same price breaks on their benefits with the convenient feeling of a payroll deduction.

HRaspirin strategy focuses on:

  • Carriers utilize our service to facilitate their payroll group payments. Agents are looking for alternatives to the billing problem. Many agents have turned to bank draft options due to expediency, but they have experienced low persistency due to volatility with personal bank accounts.

  • Employers utilize our proprietary system in house to manage carrier billing. When an employer realizes HRaspirin removes the headache, we never lose them.

  • Unions/Associations are increasingly looking to HRaspirin for dues management and data management services.

  • Some entities benefit from HRaspirin's customizable private label to manage not only their benefits, but also to export these services to other enterprises.

Shawn Stephens, President of HRaspirin stated: "We have been talking with Star for some time and see their vision for the future of their Fintech division. We bring a team of experienced professionals and software engineers that are continually improving our proprietary software. Our revenue for 2024 is expected to be around $2 million with strong net income, and with the support of the Star management team and growth funding capabilities, we anticipate that we can achieve revenues nearing $10 million for 2025."

Richard Carey, President and Chairman of Star Alliance International Corp., commented, "This is another step in our growth targets for 2024. With the addition of HRaspirin, we bring revenue and a very solid profit track record to our group. This is the second step in the growth of our Fintech division. In both these acquisitions we bring innovative and proprietary software solutions for the needs of business clients. Our team is now concentrating on our gold mine and Genesis as well as the Artificial Intelligence Company. Keep watching as we will be updating our shareholders regularly."